Citations for
1FCMD, FKTN
Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly.
Ismail S, Schaffer AE, Rosti RO, Gleeson JG, Zaki MS.
Gene 539(2):279-82. doi: 10.1016/j.gene.2014.01.070. Epub 2014 Feb 13. 2014
2FCMD, FKTN
Peripheral nerve involvement in fukuyama congenital muscular dystrophy: a case report.
Jang DH, Sung IY, Ko TS.
J Child Neurol 28(1):132-7. doi: 10.1177/0883073812437425. Epub 2012 Feb 28. 2013
3FCMD, FKTN
Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
Yis U, Uyanik G, Heck PB, Smitka M, Nobel H, Ebinger F, Dirik E, Feng L, Kurul SH, Brocke K, Unalp A, Özer E, Cakmakci H, Sewry C, Cirak S, Muntoni F, Hehr U, Morris-Rosendahl DJ.
Neuromuscul Disord 21(1):20-30. Epub 2010 Oct 18. 2011
4FCMD, FKTN
Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
Lim BC, Ki CS, Kim JW, Cho A, Kim MJ, Hwang H, Kim KJ, Hwang YS, Park WY, Lim YJ, Kim IO, Lee JS, Chae JH.
Neuromuscul Disord 20(8):524-30.PMID: 20620061 2010
5FCMD, FKTN
Fukutin gene retrotransposal insertion in a non-Japanese Fukuyama congenital muscular dystrophy (FCMD) patient.
Xiong H, Wang S, Kobayashi K, Jiang Y, Wang J, Chang X, Yuan Y, Liu J, Toda T, Fukuyama Y, Wu X.
Am J Med Genet A 149A(11):2403-8.PMID: 19842201 2009
6FKTN, FCMD
Two new patients bearing mutations in the fukutin gene confirm the relevance of this gene in Walker-Warburg syndrome.
Cotarelo RP, Valero MC, Prados B, Pe–a A, Rodr’guez L, Fano O, Marco JJ, Mart’nez-Fr’as ML, Cruces J.
Clin Genet 73(2):139-45. Epub 2007 Dec 19. 2008
7ACLS1, ACS1, AIC, ATRX, CFNS, COMA, CSS, DCX, FCMD, FCMD, FGS1, FRNS, GCPS, LJFS2, MASA, MDS, MEB, MKS1, MLS, MOWS, NBCCS2, OFD1, OGS1, OGS2, RSTS2, SOPT, WARBM1, WLKWS1, WLKWS2, XLAG
Agenesis and dysgenesis of the corpus callosum: clinical, genetic and neuroimaging findings in a series of 41 patients.
Schell-Apacik CC, Wagner K, Bihler M, Ertl-Wagner B, Heinrich U, Klopocki E, Kalscheuer VM, Muenke M, von Voss H.
Am J Med Genet A 146A(19):2501-11. 2008
8FCMD, FKTN, LARGE, POMG, POMGNT1, POMT1, POMT2, WLKWS1, WLKWS2, WLKWS3, WLKWS4
Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M, Straub V, Bushby K, Manzur A, Talim B, Cowan F, Quinlivan R, Klein A, Longman C, McWilliam R, Topaloglu H, Mein R, Abbs S, North K, Barkovich AJ, Rutherford M, Muntoni F.
Ann Neurol 64(5):573-82. 2008
9FCMD, FKTN, LARGE, POMG, POMGNT1, POMT1, POMT2, WLKWS1, WLKWS2, WLKWS3, WLKWS4
Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WWS outside of the Middle East.
Manzini MC, Gleason D, Chang BS, Hill RS, Barry BJ, Partlow JN, Poduri A, Currier S, Galvin-Parton P, Shapiro LR, Schmidt K, Davis JG, Basel-Vanagaite L, Seidahmed MZ, Salih MA, Dobyns WB, Walsh CA.
Hum Mutat 29(11):E231-41. 2008
10FCMD, FKTN
Characteristics of neurons and glia in the brain of Fukuyama type congenital muscular dystrophy.
Yamamoto T, Kato Y, Kawaguchi-Niida M, Shibata N, Osawa M, Saito K, Kröger S, Kobayashi M.
Acta Myol 27:9-13. Review.PMID: 19108571 2008
11FCMD, FKRP, FKTN, LARGE, POMG, POMGNT1, POMT1, POMT2, WLKWS1, WLKWS2, WLKWS3, WLKWS4
Muscular dystrophies due to defective glycosylation of dystroglycan.
Muntoni F, Brockington M, Godfrey C, Ackroyd M, Robb S, Manzur A, Kinali M, Mercuri E, Kaluarachchi M, Feng L, Jimenez-Mallebrera C, Clement E, Torelli S, Sewry CA, Brown SC.
Acta Myol 26(3):129-35. Review. 2007
12MDC1A, LMNA, FKTN, FCMD
Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M, Kurahashi H, Noguchi S, Sese J, Okinaga T, Tsukahara T, Guicheney P, Ozono K, Nishino I, Morishita S, Toda T.
Biochem Biophys Res Commun 342(2):489-502. Epub 2006 Feb 3. 2006
13WLKWS1, POMT1, FKTN, FCMD
Glyc-O-genetics of Walker-Warburg syndrome.
van Reeuwijk J, Brunner HG, van Bokhoven H.
Clin Genet 67(4):281-9. 2005
14FKTN, FCMD
Identification of a functional CRE in the promoter of Fukuyama congenital muscular dystrophy gene fukutin.
Fang H, Sodja C, Chartier J, Desbois A, Lei J, Walker PR, Sikorska M.
Brain Res Mol Brain Res 136(1-2):1-11. 2005
15FCMD, FKTN
Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development.
Takeda S, Kondo M, Sasaki J, Kurahashi H, Kano H, Arai K, Misaki K, Fukui T, Kobayashi K, Tachikawa M, Imamura M, Nakamura Y, Shimizu T, Murakami T, Sunada Y, Fujikado T, Matsumura K, Terashima T, Toda T.
Hum Mol Genet 12(12):1449-59. 2003
16FCMD, WLKWS1, FKTN
A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype.
de Bernabe DB, van Bokhoven H, van Beusekom E, Van den Akker W, Kant S, Dobyns WB, Cormand B, Currier S, Hamel B, Talim B, Topaloglu H, Brunner HG.
J Med Genet 40(11):845-8. No abstract available. 2003
17FCMD, FKTN
Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle.
Sunada Y, Saito F, Higuchi I, Matsumura K, Shimizu T.
Neuromuscul Disord 12(2):117-20. 2002
18FCMD, FKTN
Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy.
Yamamoto T, Kato Y, Karita M, Takeiri H, Muramatsu F, Kobayashi M, Saito K, Osawa M.
Acta Neuropathol (Berl) 104(3):217-24. Epub 2002 Jun 21. 2002
19FCMD, FKTN
Structural organization, complete genomic sequences and mutational analyses of the Fukuyama-type congenital muscular dystrophy gene, fukutin.
Kobayashi K, Sasaki J, Kondo-Iida E, Fukuda Y, Kinoshita M, Sunada Y, Nakamura Y, Toda T.
FEBS Lett 489(2-3):192-6. 2001
20WLKWS1, MEB, FCMD, FKTN
Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease.
Cormand B, Pihko H, Bayes M, Valanne L, Santavuori P, Talim B, Gershoni-Baruch R, Ahmad A, van Bokhoven H, Brunner HG, Voit T, Topaloglu H, Dobyns WB, Lehesjoki AE.
Neurology 56(8):1059-69. 2001
21FCMD, FKTN
Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K.
Neurology 57(1):115-21. 2001
22FCMD, FKTN
Haplotype-phenotype correlation in Fukuyama congenital muscular dystrophy.
Saito K, Osawa M, Wang ZP, Ikeya K, Fukuyama Y, Kondo-Iida E, Toda T, Ohashi H, Kurosawa K, Wakai S, Kaneko K.
Am J Med Genet 92(3):184-90. 2000
23FCMD, FKTN
Fukutin protein is expressed in neurons of the normal developing human brain but is reduced in Fukuyama-type congenital muscular dystrophy brain.
Saito Y, Mizuguchi M, Oka A, Takashima S.
Ann Neurol 47(6):756-64. 2000
24FCMD, FKTN
Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD).
Kondo-Iida E, et al.
Hum Mol Genet 8(12):2303-2309 1999
25FCMD, FKTN
Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration.
Toda T, Kobayashi K.
J Mol Med 77(12):816-23. Review. 1999
26FCMD, FKTN
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy.
Kobayashi K, et al.
Nature 394 : 388-392. 1998
27FCMD, FKTN
Founder-haplotype analysis in Fukuyama-type congenital muscular dystrophy (FCMD).
Kobayashi K, et al.
Hum Genet 103 : 323-327. 1998
28FCMD, FKTN
Molecular genetic evidence of clinical heterogeneity in Fukuyama-type congenital muscular dystrophy.
Kondo-Iida E, et al.
Hum Genet 99 : 427-432. 1997
29FCMD, FKTN, MUSK, D9S2105, D9S2107, D9S2109
Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb.
Toda T, et al.
Am J Hum Genet 59 : 1313-1320. 1996
30FCMD, WLKWS1, FKTN
Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome.
Toda T, et al.
Ann Neurol 37 : 99-101. 1995
31FCMD, FKTN
Muscle-eye-brain disease and Fukuyama type congenital muscular dystrophy are not allelic.
Ranta S, et al.
Neuromuscul Disord 5 : 221-225. 1995
32FCMD, LAMA2, WLKWS1, FKTN
Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
Voit T, Sewry CA, Meyer K, Hermann R, Straub V, Muntoni F, Kahn T, Unsold R, Helliwell TR, Appleton R, et al.
Neuropediatrics 26(3):148-55. 1995
33FCMD, FKTN
Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy.
Yoshioka M, et al.
Am J Med Genet 53 : 245-250. 1994
34FCMD, FKTN
Refined mapping of a gene responsible for Fukuyama-type congenital muscular dystrophy : evidence for strong linkage disequilibrium.
Toda T, et al.
Am J Hum Genet 55 : 946-950. 1994
35FCMD, FKTN
Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.
Matsumura K, et al.
Lancet 341 : 521-522. 1993
36FCMD, FKTN
Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.
Toda T, et al.
Nat Genet 5 : 283-286. 1993
37FCMD, FKTN
Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.
Beggs AH, et al.
Proc Natl Acad Sci U S A 89 : 623-627. 1992
38FCMD
Muscle-eye-brain disease (MEB).
Santavuori P, et al.
Brain Dev 11 : 147-153. 1989